To assess the direct and indirect effects of the commonly used calcium entry blockers (CEB) upon the major determinants of isovolumic left ventricular relaxation, we administered equidepressant intracoronary (IC, n = 7) and equihypotensive intravenous (n = 12) dosages of diltiazem (16 +/-3 SE micrograms/kg IC and 63 +/-9 micrograms/kg i.v.), verapamil (10 +/-2 and 57 +/-5 micrograms/kg), and nifedipine (1 +/-0.1 and 8 +/-0.3 micrograms/kg) to preinstrumented awake dogs with normal ventricular function. The time constant of left ventricle (LV) relaxation, analyzed by two methods (T1, from the linear relation of the natural logarithm of LV pressure and time; T2, from the linear relation of LV pressure and negative high fidelity LV pressure), was significantly and equivalently prolonged by IC diltiazem (T1 + 48%, P less than 0.02), verapamil (T1 + 43%, P less than 0.001), and nifedipine (T1 + 30%, P less than 0.03). Lesser amounts of each CEB that did not affect rate of LV pressure development or extent of shortening produced no change in T1 or T2. By contrast, intravenous calcium entry blockade either produced no significant change (diltiazem and verapamil) or shortened (nifedipine T1 -18%, P less than 0.01) LV isovolumic relaxation. However, after beta adrenergic blockade with propranolol (2 mg/kg i.v., n = 6) no change in 
Introduction
Calcium entry blocking drugs are now widely used in the treatment of a variety of cardiovascular disorders (1) . There have been many studies concerning the effects of these agents on systolic ventricular performance (2-6) in preinstrumented conscious dogs, but little is known about their effects upon normal diastolic properties of the left ventricle. In particular, the potential role of the reduction of transcellular myocardial calcium influx by pharmacologic calcium entry blockade in modulating left ventricular pressure decay is unclear.
Several clinical investigations (7-9, 9a) have suggested that calcium entry blockers (CEB)' may enhance ventricular relaxation in patients with hypertrophic cardiomyopathy or ischemic heart disease, and thus contribute to clinical improvement of such patients. However, the mechanism of these salutary effects is uncertain because of the difficulties encountered in distinguishing the relative contribution of reflex sympathetic stimulation, altered ventricular loading, and direct myocardial effects evoked by these agents on the relaxation process (10). There is also no information available regarding the relative effects of the commonly used calcium entry blocking agents upon isovolumic left ventricular relaxation. We designed the present investigation to assess the effects of calcium entry blockade upon the major determinants of normal myocardial relaxation, and to assess the comparative effects of the commonly used calcium channel blockers diltiazem, verapamil, and nifedipine on the ventricular relaxation process.
Methods
Canine preparation. 19 healthy adult mongrel dogs (18-30 kg) were surgically instrumented for long term physiologic monitoring by methods previously described for this laboratory (1 1). Dogs were premedicated with xylazine and pentobarbital (15 mg/kg). Endotrachial intubation was performed and the dogs were ventilated with 1.5% halothane anesthesia. The chest was opened in the fifth left intercostal space under sterile conditions. The pericardial sac was incised parallel to the phrenic nerves and left widely open. Polyvinyl 16-gauge catheters were implanted in the descending aorta, apical left ventricle (LV), and superior vena cava. A solid state micromanometer pressure transducer (P-18, Konigsberg Instruments, Inc., Pasadena, CA) was placed in the apex of the LV. Seven of these dogs (group I) were instrumented with proximal circumflex coronary artery catheters for intracoronary (IC) drug administration (4) and miniature 2 mm subendocardial ultrasonic segment gauge pairs for measuring percentage of regional myocardial shortening in the circumflex area (LV base) as determined by the area of cyanosis produced by transient coronary occlusion during instrumentation. These animals also had regional segment crystal pairs similarly placed in the area perfused by the left anterior descending coronary artery (LV apex). The regional ultrasonic crystal pairs were aligned perpendicular to the long-axis and parallel to circumferential hoop fibers of the LV wall close to the endocardium according to the method of Franklin et al. (12) .
In the remaining 12 dogs (group 2), two 5-mHz piezoelectric crystals (4 mm in diameter) were also implanted along the greatest internal left ventricular transverse diameter, one on the anterior and the other on the posterior endocardial wall for continuous measurement of LV internal dimension and global percentage of shortening (13) in lieu of regional crystal pairs. In six of these dogs, electromagnetic cuff type flow probes (Zepeda Instruments, Seattle, WA) were placed around the ascending aorta. All wires and tubes were tunneled subcutaneously to the back of the neck and dogs were allowed to recover for a minimum of 2 wk before experimentation.
Data collection. Each study was performed with the dog lying quietly on the right side in a sling. The left ventricular and aortic catheters were connected to Statham P23DB pressure transducers precalibrated with a mercury manometer using the vertebral column as the zero reference point and atmospheric pressure as the zero reference. The left ventricular pressure signal from the micromanometer was adjusted to match that obtained from the fluid-filled catheter. The first derivative of left ventricular pressure was obtained electronically from the micromanometer signal using an RC circuit with a linear frequency response to 70 Hz and 3dB down at 100 Hz. The transit time of 5 mHz ultrasound between ultrasonic crystal pairs was measured with a multichannel sonomicrometer (Scheussler and Assoc., San Diego, CA) using the electronics of Franklin (12) and was converted to distance assuming constant velocity of sound in blood of 1.55 mm/ ,gs. The resolution of this system has been reported at 0.07 mm with 5 -mHz signals (13) . High fidelity and fluid LV pressure, the first derivative of high fidelity LV pressure (dP/dt), aortic pressure, aortic flow velocity, and the dimensions of regional (group 1) or transverse LV diameter (group 2) ultrasonic crystal pairs were recorded on an 8 channel forced-ink pen oscillograph (Beckman Instruments Inc., Fullerton, CA) at a paper speed of 25 mm/s. The analogue signals were also digitized with an on-line analogue to digital convertor (Dual Control Systems, Los Angeles, CA) at 5-ms intervals and stored on floppy discs using a minicomputer system (Zobex Systems, Los Angeles, CA) and software developed in our laboratory.
Data analysis. Data were analyzed by means of computer algorithm. End-diastolic transverse dimension and segment length were defined as the distance between ultrasonic crystal pairs at the Z-point of the high fidelity left ventricular pressure signal or as the LV pressure at which +dP/dt increased by 150 mmHg/s with the increase sustained for at least 50 ms when no A wave was present at higher heart rates. End-systolic lengths were measured at the minimum intercrystal distance before (-)dP/dt max, which corresponds to maximal segmental shortening during left ventricular ejection in the normal left ventricle (14, 15) . In all experiments, both during the control state and during the peak effect of each IC calcium entry blocker, the minimum regional segment end-systolic dimension occurred before (-)dP/dt max. Percentage of shortening of the LV transverse diameter signal and regional shortening were calculated as the end-diastolic length minus the endsystolic length divided by the end-diastolic length times 100. Cardiac output was measured as the product of the stroke volume (obtained by integration of the ascending aortic flow probe velocity signal) times the heart rate. Signals for 10-15 sinus beats were averaged for each data point. Post-premature beats and beats that varied >10% in cycle length from the average heart rate were excluded from analyses.
Two approaches were applied for the measurement of the rate of isovolumic relaxation: the maximum rate of isovolumic pressure fall (16) Group 2 (n = 12) systemic intravenous drug administration. In order to discern the integrated direct myocardial, peripheral arterial dilatation and reflex sympathetic effects (24) of the CEB upon isovolumic relaxation, we administered intravenous equihypotensive infusions of diltiazem, verapamil, and nifedipine (63±9, 57±5, and 8±3 'sg/kg per min, respectively) using a Harvard infusion pump on different days after 0.05 mg/kg atropine i.v. Identical infusions of the three CEB were subsequently given to six of these dogs after 2 mg/kg of intravenous propranolol. This dose of propranolol has been shown to abolish the effects of isoproterenol (4-6 gg/kg) on heart rate and (+)dP/dt max for 45 min (4 Table I and Figs. 1-7. Both diltiazem and nifedipine produced modest but insignificant increases in heart rate (diltiazem 109±13-123±16, nifedipine 124±14-126±9, both P = NS). By contrast, IC verapamil reduced heart rate from 127±13 to 85±9 (P < 0.05) in these dogs. All three CEB produced declines in mean aortic pressure from 106±5 to 88±5 mmHg (P < 0.04) for diltiazem; from 105±4 to 89±6 mmHg (P < 0.02) for verapamil and from 102±6 to 90±5 mmHg (P < 0.05) for nifedipine ( Fig. 3 ). Left ventricular end-diastolic pressure was substantially increased by IC diltiazem from 8±2 to 12±2 mmHg (P < 0.01), by verapamil from 5±1 to 16±2 mmHg (P < 0.001), and by nifedipine from 5±1 to 12±2 mmHg (P < 0.05). The increase in left ventricular end-diastolic pressure (LVEDP) after verapamil was greater (P < 0.005) than that observed after diltiazem or nifedipine. The first derivative of LV pressure ([+JdP/dt max) was reduced from 2,990±325 to 2,470±640 mmHg/s (<0.01) by diltiazem, from 3,152±360 to 2,367±242 mmHg/s (P < 0.02) by verapamil, and from 2,875±286 to 2,445±288 mmHg/s (P < 0.03) by nifedipine (Fig. 4) . The reduction in dP/dt max did not differ significantly among the three CEB (P = NS by ANOVA). By experimental design, the doses of the CEB were selected to produce equivalent reductions in percentage of regional shortening of the LV base (Table I) . Basal LV shortening was reduced from 14±2 to 10±2% (P < 0.03) by diltiazem, from 14±2 to 10±2% (P < 0.05) by verapamil and from 12±2 to 9±1% (P < 0.02) by nifedipine (all P = NS among drugs by ANOVA). Apical LV shortening was similarly reduced by circumflex intracoronary administration of all three CEB (Table I, Fig. 5 ).
Effects of IC calcium entry blockade upon isovolumic LV relaxation. All three CEB produced equivalent and substantial declines in the indices of isovolumic relaxation (Table I and Figs. 1 and 2 ). Diltiazem reduced (-)dP/dt max from 2,636±197 to 2,363±739 mmHg/s (P < 0.01); verapamil from 2,450±255 to 1,594±207 mmHg/s (P < 0.02); and nifedipine from 2,449±233 to 1,399±234 mmHg/s (P < 0.03) (Fig. 6) .
The effects of IC calcium entry blockade upon the time constant of LV isovolumic relaxation obtained by linear regression of the natural logarithm of pressure versus time (T1) are evident in Fig. 1 and Table I . Fig. 1 demonstrates the semilogarithmic plots of LV pressure versus time pre-and postdiltiazem, verapamil, and nifedipine in a single dog. In each case, the slope of the lines of best fit of these data points was reduced and the time constant (T1) prolonged compared to the respective control after IC CEB administration. Group data are displayed in Table I . T1 was increased from 16±3 to 31±11 ms (P < 0.02) after diltiazem, from 16±2 to 28±5 ms (P < 0.001) after verapamil, and from 16±3 to 23±5 ms (P < 0.03) after nifedipine (P = NS among drugs by ANOVA) (Fig. 7) . T2 was similarly and significantly prolonged by each of the calcium blockers (Table I, Fig. 2 ). T2 was prolonged by 21% with diltiazem (P < 0.02), by 30% with verapamil (P < 0.05), and by 24% with nifedipine (P < 0.02). Although PB (at 0 dP/dt) tended to rise with each CEB, the increase was only significant with verapamil (-10±5±2 mmHg, P < 0.05).
Group 2-effects of equihypotensive intravenous infusions of calcium entry blockers upon systolic function pre-and postbeta blockade. Steady state hemodynamic changes produced during calcium blocker infusion are summarized in Table II . All three drugs evoked equivalent increases in heart rate (range 15-20%, P = NS among drugs by ANOVA). Heart rate was increased from 117±8 to 137±9 beats/min (P <0.006) by diltiazem, from 125±8 to 155±10 beats/min (P < 0.003) by verapamil, and from 115+9 to 146+10 beats/min (P < 0.004) by nifedipine. Post-beta blockade (n = 6) similar directional changes in heart rate were observed with each drug; however, the increments were significantly attenuated compared with those observed with calcium entry blockade alone (Table II , P < 0.05 for verapamil and nifedipine). Intravenous diltiazem reduced mean aortic pressure from 99+4 to 89+3 mmHg (P < 0.001), verapamil from 98±5 to 90±4 mmHg (P < 0.02), and nifedipine from 99±4 to 90±4 mmHg (P < 0.02). Postbeta blockade there was no significant decline in systemic arterial pressure with any of the calcium blockers despite use of the same dose that was employed before propranolol (Table II) . Neither LV end-diastolic pressure nor transverse diameter were significantly altered with any of the calcium blockers preor post-beta adrenergic blockade. Percentage of shortening of the LV minor diameter signal (%AD) increased from 17±1 to 19±1 (P = NS) with diltiazem, from 18 to 20% (P = NS) with nifedipine, and remained unchanged at 17±2% with verapamil (P < 0.05 vs. diltiazem, P < 0.008 vs. nifedipine). LV percentage of shortening with each drug postpropranolol was significantly reduced when compared with percentage of shortening with the respective calcium blocker alone (Table II) . Extent of LV shortening was significantly less after the combination of propranolol and verapamil (14±2%) than after beta blockade plus either diltiazem or nifedipine (each 16±2, P < 0.03 vs. verapamil). Cardiac output was unchanged from control after diltiazem (1.96±0.27-2.25±0.37 liter/min, P = NS) or verapamil (2.05±0.36-1.85±0.31 liter/min, P = NS) and was increased by the equihypotensive infusion of nifedipine (1.95±0.34-2.60±0.50 liter/min, P < 0.04). Post-beta blockade cardiac output was significantly increased by diltiazem (1.93±0.31-2.20±0.25 liter/min, P < 0.02) and nifedipine (1.97±0.3-2.22±0.25 liter/min, P < 0.04), but unchanged by verapamil (2.05±0.29-2.39+0.22, P = NS).
In the doses used in this investigation, no significant change from control in (+)dP/dt max was observed during intravenous calcium blocker administration. However, the group mean for dP/dt max during verapamil administration (2,599+286 mmHg/s) was significantly less than that observed during either diltiazem (2,740±242 mmHg/s, P < 0.05) or nifedipine (2,934±260 mmHg, P < 0.02). Similarly, post-beta blockade, the group mean for dP/dt max with verapamil (1,775+170 mmHg/s) was significantly depressed relative to diltiazem (2,245±123 mmHg/s, P < 0.02) and nifedipine (2,206+116 mmHg/s, P < 0.02). Group means for (+)dP/dt max for each of the combinations of beta blockade plus diltiazem, verapamil, and nifedipine were significantly less than the group means observed during calcium entry blockade alone, each P < 0.05.
Effects of intravenous calcium entry blockade upon isovolumic LV relaxation. In contrast to the significant reductions in (-)dP/dt max observed in response to intracoronary diltiazem, verapamil, and nifedipine (Table I) , intravenous equihypotensive calcium blocker administration produced no change in the rate of isovolumic LV pressure fall (Table II) T1, the time constant of LV relaxation was not altered by either intravenous diltiazem (16±2-15±1 ms, P= NS) or verapamil (15±2-15±2 ms). However, intravenous nifedipine significantly reduced T. (17±1-14+2 ms, P < 0.01). This effect was abolished after beta adrenergic blockade (16±3-16±1 ms). Postpropranolol, verapamil significantly prolonged T. from 17±2 to 20±1 ms (P < 0.05). Similar directional changes in T2 were observed for each of the calcium blockers pre-and post-beta blockade. The PB at 0 dP/dt was not significantly changed from control by intravenous calcium entry blockade before or during propranolol (Table II) .
Discussion
The results of this investigation suggest that calcium entry blockade produces divergent effects upon the dissipation of left ventricular force that are dependent upon the mode of drug administration. These agents directly impair relaxation in normal ventricular myocardium. However, this action may be attenuated or even reversed during systemic administration because of the concomitant effects of calcium blockade upon ventricular loading conditions and reflex sympathetic stimulation. We used the intracoronary route to observe direct drug effects independent of reflex changes and the intravenous route to compare the effects of the three widely used calcium blockers on overall LV performance in conscious dogs with reflexes intact. The IC bolus injection of diltiazem, verapamil, and nifedipine in dosages that produced equivalent reductions in the extent of LV chamber shortening and rate of pressure development (hereafter referred to as equidepressant) evoked significant declines in the rate of isovolumic relaxation as assessed by (-)dP/dt max and T, the time constant of LV pressure decay (Table I, Figs. 1 and 2 ). Lesser amounts of each of these agents that were without effect upon systolic LV performance were also without discernable effect upon diastolic relaxation. By contrast, the intravenous infusion of the CEB pre-beta blockade in dosages that reduced arterial pressure equally (hereafter called equihypotensive) either substantially augmented ventricular relaxation (nifedipine) or produced no significant change in (-)dP/dt max or either measure of T (diltiazem and verapamil, (27) . The dosages of the CEB employed for IC administration produced equivalent effects upon the rate of LV pressure development, extent of LV muscle shortening, and loading conditions. The substantial reduction in pressure development and muscle shortening produced by calcium entry blockade may retard LV relaxation by diminishing external LV chamber restoring forces (i.e., the potential energy stored during systolic deformation). All shown to have an inverse effect upon the duration of the time constant in the awake dog (28), the magnitude of change required is considerably in excess of that which we observed with verapamil. Neither nifedipine nor diltiazem affected heart rate in these atropinized dogs, and yet each drug impaired LV relaxation. Mechanical dyssynchrony may also impair global ventricular pressure decay if delayed activation produces late regional contraction of a myocardial segment during isovolumic relaxation (27) . Although we cannot entirely exclude temporal inhomogeneity of ventricular activation/deactivation as a contributory determinant of the impaired relaxation observed with circumflex intracoronary calcium entry blockade, such an effect seems unlikely since (a) minimum regional segment length always occurred before peak (-)dP/dt during calcium Figure 5 . Each of the CEB produced significant reductions from their respective controls (C) in percentage of regional shortening of the basal LV. The decrease in regional shortening was equivalent among the agents by experimental design. Similar decreases in shortening were observed in the apical LV region (see Table I ).
blockade despite diminished extent of shortening; (b) segment lengths were unchanged during the period of isovolumic relaxation; and (c) both basal and apical LV segments evidenced reduced shortening during drug administration. These results differ somewhat from the data of Serruys and coworkers (29) who observed that minimal separation of epicardial regional marker pairs occurred after end-systole (as determined by aortic incisura pressure) subsequent to intrabypass injection of 100 jig of nifedipine in patients post-coronary revascularization.
These differences may be explained by the relatively greater amount of myocardium supplied by the circumflex coronary artery and the abundance of native collaterals observed in the dog in contrast to man (30 sufficient to augment LV dP/dt max by 20% (2-9 mg/kg) in the conscious dog. The variance between these studies may be explained by the differences in the concentration of extracellular calcium attained and by the differences in the distribution of load during isotonic papillary muscle and auxotonic ventricular chamber shortening coupled with a potentially greater role for external restoring forces as a determinant of relaxation in the ejecting heart (35) . Importantly, neither study indicates that changes in transcellular calcium flux may affect ventricular relaxation of normal cardiac muscle independent of alterations in loading.
IC calcium entry blockade with all three drugs in equidepressant dosages produced substantial prolongations of ventricular relaxation as assessed by (-)dP/dt and T, the time constant of LV relaxations ( Table I ).
intravenous equihypotensive infusions of the CEB evoked either a significant decrease in T1 and T2 (nifedipine) or no significant change in this measure of relaxation (diltiazem and verapamil) ( Table II) . The small and statistically insignificant reductions in (-)dP/dt max (Table II) after all three drugs may be explained by the well known sensitivity of the first derivative of LV pressure fall to the level of systemic arterial pressure (16) . The relative improvement in ventricular relaxation observed after intravenous as compared with IC calcium blockade may be explained by the preponderance of reflex and peripheral changes over direct myocardial effects during systemic administration. The reduction in systemic arterial pressure produced during calcium blocker infusions was associated with modest but significant increases in heart rate secondary to baroreceptor-mediated sympathetic stimulation and vagal withdrawal (4, 5) . Nonselective beta adrenergic blockade attenuated but did not reverse the increase in heart rate during calcium blockade and was associated with either no improvement (nifedipine and diltiazem) or a decrease (verapamil) in isovolumic relaxation. The differential effects of systemic calcium entry blockade upon the rate of LV pressure decay pre-and postpropranolol suggests an important role for the sympathetic nervous system in modifying or reversing the direct effects of these compounds on the relaxation process. Sympathetic agonists have been demonstrated to enhance relaxation in both isometrically and isotonically contracting cardiac muscle (24, 34) in the isolated heart (17) and in conscious animals (28) . Although dP/dt max was not reflexly increased during drug infusion, catecholamines, unlike calcium, have been shown to improve ventricular relaxation independent of their effects upon load. For example, in isolated rat hearts calcium produced symmetrical changes in the velocity of contraction and relaxation (36) , whereas isoproterenol increased the velocity of relaxation more than the velocity of contraction. Extent of shortening and rate of pressure development were reduced with each of the CEB plus propranolol compared with calcium blockade alone (Table II) , and may have contributed to the unfavorable changes in relaxation observed with nifedipine and verapamil post-beta blockade (Table II) . Other factors seem less likely to explain the improvement in relaxation observed during systemic nifedipine. Ventricular preload (LV dimension and pressure) was not altered by nifedipine despite the decline in aortic pressure. Although increases in heart rate produced by atrial pacing alone may produce a moderate reduction in the time constant of LV relaxation in awake dogs (28) , the increment in heart rate produced by pacing (+50%) necessary to produce such changes was considerably greater than the heart rate increment during nifedipine in this study (+27%).
Several recent clinical investigations have emphasized the presence of abnormalities of ventricular filling in patients with hypertrophic cardiomyopathy (7, 9) course of relaxation and filling, the reduced time to peak filling could be ascribed to a shortening of isovolumic relaxation time, a shortening of the rapid-filling period, or both of these phases of diastole. Paulus and colleagues (9) did observe a decrease in the time constant of relaxation with nifedipine during cardiac catheterization in patients with hypertrophic cardiomyopathy. However, a similar reduction in T was observed after equihypotensive nitroprusside. The results of this study and our data suggest that favorable alterations in ventricular loading and reflex sympathetic stimulation produced by calcium entry blockade may importantly affect these observed alterations in diastolic function. Although the current investigation involved acute administration of CEB, we have observed significant elevations in circulating catecholamines at rest and during exercise with chronic oral diltiazem therapy in patients with coronary artery disease (37) .
It is important to emphasize that our observations regarding the depressant effect of calcium entry blockade upon ventricular relaxation were made in the normal heart. Pathologic intracellular calcium overload produced by elevating external calcium concentration from 0.9 to 8 mM in cultured chick embryo ventricular cells (38) and by ischemic myocardial contracture in the isolated rabbit heart (39) has been associated with impaired velocity of relaxation and elevated end diastolic pressures, respectively. Preadministration of verapamil (2 X 10-8 M) improved relaxation of the isolated calcium overloaded cell and nifedipine (1 X l0-7 M) prevented the abnormal elevation of diastolic pressure in the isolated ischemic heart. In the clinical setting, pacing-induced angina pectoris in patients with coronary artery disease is associated with impaired ventricular relaxation and elevated end diastolic pressures (40) . This impairment of relaxation during acute ischemia has been prevented using nifedipine (41). In 
